NSE ScannerFMCG & Food · Food: Major Diversified · NSE: ZYDUSWELL · data 2026-11-01
Zydus Wellness Limited
In plain words
Price: 24.4% below its 52-week high of ₹611.85.
Delivery: 44.4% of traded shares were kept for delivery over the last 10 sessions, against 43.7% over the last 60.
Latest results: a net profit of ₹119 cr for the quarter ended Jun 2026 (-7.0% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹4,537 cr |
| Net profit (last 12 months) | ₹188 cr |
| Sales growth, 3 years (yearly) | 20.6% |
| Profit growth, 3 years (yearly) | -14.0% |
At a glance
Promoters 69.6% (unchanged in a year), pledged 0.0%, institutions 22.9%.
P/E 78.2, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).
ROE 3.4%, ROCE 4.5%, operating margin 8.7%: how much profit it earns on the money it uses.
Debt/equity 0.55, Profit growth -14.0% and sales growth 20.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (3.4%).
- Profit fell 14.0% a year over 3 years.
- Expensive on earnings (P/E 78.2).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
ZYDUSWELL Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹1,437 crore, up 66.9% YoY and down 3.2% QoQ.
Net profit was ₹118.9 crore, down 7% YoY and down 26.6% QoQ.
Operating margin was 16.8% (18.1% a year ago).
EPS was ₹3.74, down 7% YoY and down 26.5% QoQ.
ZYDUSWELL के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹1,437 करोड़; पिछले साल की तुलना में 66.9% की बढ़त, पिछली तिमाही की तुलना में 3.2% की गिरावट।
शुद्ध मुनाफ़ा: ₹118.9 करोड़; पिछले साल की तुलना में 7% की गिरावट, पिछली तिमाही की तुलना में 26.6% की गिरावट।
ऑपरेटिंग मार्जिन: 16.8% (एक साल पहले 18.1%)।
EPS: ₹3.74; पिछले साल की तुलना में 7% की गिरावट, पिछली तिमाही की तुलना में 26.5% की गिरावट।
ZYDUSWELLના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹1,437 કરોડ; ગયા વર્ષની સરખામણીએ 66.9% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 3.2% ઘટાડો.
ચોખ્ખો નફો: ₹118.9 કરોડ; ગયા વર્ષની સરખામણીએ 7% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 26.6% ઘટાડો.
ઓપરેટિંગ માર્જિન: 16.8% (એક વર્ષ પહેલાં 18.1%).
EPS: ₹3.74; ગયા વર્ષની સરખામણીએ 7% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 26.5% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
24/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 44.7% over the last 20 sessions vs 26.4% in the 40 before (1.69x); shares delivered per day 0.4x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 9/15: 4 schemes hold it, about ₹2,129 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results ● Split
- 17 Jul 26Dividend Dividend ₹1.2 (ex-date) +0.1% next session
- 3 Feb 26Results Q3 FY26 results: turned to loss vs a year ago -7.8% next session
- 18 Sept 25Split Split: face value ₹10 → ₹2 (ex-date)
- 30 Jul 25Results Q1 FY26 results: net profit ₹127.9 cr +0.8% next session
- 11 Jul 25Dividend Dividend ₹6 (ex-date) -0.1% next session
- 4 Feb 25Results Q3 FY25 results: net profit ₹6.4 cr -3.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹1,437 cr | ₹119 cr | -7.0% | 16.8% | 3.74 |
| Mar 2026 | ₹1,485 cr | ₹162 cr | -5.8% | 18.2% | 5.09 |
| Dec 2025 | ₹965 cr | ₹-40 cr | -723.4% | 6.3% | -1.25 |
| Sept 2025 | ₹651 cr | ₹-53 cr | -352.6% | 3.5% | -1.66 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 69.64% | 69.64% | 69.63% | 69.63% |
| Foreign institutions (FII) | 3.56% | 3.32% | 3.18% | 3.27% |
| Domestic institutions (DII) | 19.39% | 19.14% | 18.87% | 18.58% |
| Mutual funds | 18.72% | 18.73% | 18.43% | 18.11% |
| Retail investors | 5.20% | 5.45% | 5.43% | 5.60% |
| Number of shareholders | 86,160 | 86,866 | 80,671 | 80,105 |
Common questions
What was Zydus Wellness Limited's latest quarterly profit?
Zydus Wellness Limited reported a net profit of ₹119 cr for the quarter ended Jun 2026 (-7.0% on the same quarter a year earlier), on revenue of ₹1,437 cr.
How much do promoters hold in Zydus Wellness Limited?
Promoters held 69.64% of Zydus Wellness Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Zydus Wellness Limited debt-free?
Its latest reported debt-to-equity ratio is 0.55.
What is Zydus Wellness Limited's P/E ratio?
About 78.2, based on the last 12 months' earnings and a price of ₹462.75 (data 2026-11-01).
What is the 52-week high and low of Zydus Wellness Limited?
The 52-week high is ₹611.85 and the 52-week low is ₹367.55.
Mutual funds holding Zydus Wellness Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹2,129 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Parag Parikh Flexi Cap Fund | PPFAS Mutual Fund | 0.78% | ₹1,132 cr |
| NIPPON INDIA SMALL CAP FUND | Nippon India Mutual Fund | 1.09% | ₹882 cr |
| Parag Parikh ELSS Tax Saver Fund | PPFAS Mutual Fund | 1.10% | ₹59 cr |
| Nippon India Consumption Fund | Nippon India Mutual Fund | 2.48% | ₹56 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Zydus Wellness Limited | ₹462.75 | ₹14,707 cr | 78.2 | — | 3.4% | 4.5% | 0.55 | -6.6% |
| Nestle India Ltd. | ₹1,167 | ₹2,25,613 cr | 55.2 | 39 | 76.3% | 57.7% | 0.09 | -8.7% |
| Bombay Burmah Trading Corp. Ltd. | ₹1,147.2 | ₹8,002 cr | 6.2 | — | 19.6% | 34.1% | 0.23 | -43.5% |
| Sanstar Limited | ₹94.91 | ₹1,899 cr | 39.4 | — | 5.1% | 2.6% | 0.03 | -1.9% |
| Dhunseri Ventures Limited | ₹267.5 | ₹946 cr | 4.8 | — | 2.8% | -0.5% | 0.29 | -19.9% |
| BCL Industries Ltd | ₹30.16 | ₹890 cr | 7.6 | — | 13.4% | 15.9% | 0.63 | -26.0% |
Compare ZYDUSWELL with NESTLEIND in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ZYDUSWELL in NSE Scanner →